The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status

BACKGROUND: To evaluate the eosinophil changes, efficacy and safety of pembrolizumab treatment in advanced urothelial carcinoma patients of older age and those with a poor performance status (PS). MATERIALS AND METHODS: Consecutive patients with advanced UC who received pembrolizumab after the failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Furubayashi, Nobuki, Minato, Akinori, Negishi, Takahito, Sakamoto, Naotaka, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Harada, Mirii, Tamura, Shingo, Kobayashi, Hiroki, Wada, Yamato, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645692/
https://www.ncbi.nlm.nih.gov/pubmed/36388155
http://dx.doi.org/10.2147/OTT.S389138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645692/
https://www.ncbi.nlm.nih.gov/pubmed/36388155
http://dx.doi.org/10.2147/OTT.S389138

Ejemplares similares